Charles Schwab Investment Management Inc. acquired a new stake in Everus (NYSE:ECG – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 411,113 shares of the company’s stock, valued at approximately $27,031,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. SRS Capital Advisors Inc. purchased a new stake in shares of Everus during the fourth quarter valued at $26,000. Principal Securities Inc. bought a new stake in Everus during the 4th quarter valued at about $27,000. HighMark Wealth Management LLC purchased a new stake in Everus in the 4th quarter valued at about $28,000. Crews Bank & Trust bought a new position in Everus in the 4th quarter worth about $29,000. Finally, Mendota Financial Group LLC purchased a new position in shares of Everus during the fourth quarter worth approximately $36,000.
Insider Buying and Selling at Everus
In other Everus news, CFO Maximillian J. Marcy bought 1,300 shares of the company’s stock in a transaction that occurred on Tuesday, February 25th. The shares were purchased at an average cost of $38.99 per share, for a total transaction of $50,687.00. Following the purchase, the chief financial officer now directly owns 5,508 shares in the company, valued at $214,756.92. This represents a 30.89 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Rocca Michael Della purchased 1,050 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the completion of the purchase, the director now owns 2,027 shares of the company’s stock, valued at $96,404.12. The trade was a 107.47 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 3,750 shares of company stock valued at $153,853.
Everus Stock Performance
Everus (NYSE:ECG – Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.06). On average, equities analysts forecast that Everus will post 2.49 EPS for the current fiscal year.
Analyst Ratings Changes
ECG has been the topic of several research analyst reports. Oppenheimer raised their price objective on Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, January 7th. Wolfe Research assumed coverage on Everus in a research report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus lowered their price objective on shares of Everus from $85.00 to $67.00 and set a “buy” rating for the company in a research note on Thursday, February 13th.
Read Our Latest Stock Analysis on Everus
Everus Company Profile
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Further Reading
- Five stocks we like better than Everus
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Can TikTok Stock Picks Really Make You Rich?
- Compound Interest and Why It Matters When Investing
- The “Quality” Rotation: Back to Basics Investing
- Learn Technical Analysis Skills to Master the Stock Market
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECG – Free Report).
Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.